Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hymecromone in Primary Sclerosing Cholangitis
NCT05295680Phase 2Recruiting
- Start
- May 2023
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hymecromone in Primary Sclerosing Cholangitis (PSC). Started May 2023; status: recruiting.
02
Drugs
hymecromone
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT05295680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05295680.